CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-11 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −4,470 | $127.92 | $572K | 5,412,146 |
| 2023-05-11 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −200 | $128.84 | $26K | 5,411,946 |
| 2023-05-11 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 507,155 | ||
| 2023-05-10 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-05-10 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −16,954 | $131.08 | $2.2M | 5,434,992 |
| 2023-05-10 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −21,247 | $131.89 | $2.8M | 5,413,745 |
| 2023-05-10 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −1,499 | $132.97 | $199K | 5,412,246 |
| 2023-05-10 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −300 | $133.71 | $40K | 5,411,946 |
| 2023-05-10 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 547,155 | ||
| 2023-05-10 | Hoge Stephen President | Sale 10b5-1 | −250 | $133.37 | $33K | 1,630,732 |
| 2023-05-09 | Hoge Stephen President | Exercise or conversion 10b5-1 | +522 | 1,630,982 | ||
| 2023-05-09 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −522 | 3,657 | ||
| 2023-05-04 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-05-04 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −600 | $132.98 | $80K | 5,451,346 |
| 2023-05-04 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −2,846 | $134.32 | $382K | 5,448,500 |
| 2023-05-04 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −13,468 | $135.06 | $1.8M | 5,435,032 |
| 2023-05-04 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −16,552 | $136.01 | $2.3M | 5,418,480 |
| 2023-05-04 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −5,427 | $136.97 | $743K | 5,413,053 |
| 2023-05-04 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −1,107 | $137.76 | $153K | 5,411,946 |
| 2023-05-04 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 587,155 |
Page 47 of 66 · 1,314 trades